CSIMarket Company Name, Ticker, Competitors, else..
 
Procyon Corporation  (PCYN)
Other Ticker:  
 
 
Price: $0.1800 $0.00 0.000%
Day's High: $0.18 Week Perf: -5.36 %
Day's Low: $ 0.18 30 Day Perf: -4.31 %
Volume (M): 5 52 Wk High: $ 0.34
Volume (M$): $ 1 52 Wk Avg: $0.21
Open: $0.18 52 Wk Low: $0.17



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Procyon Corporation
Procyon Corporation is a technology and engineering company that specializes in the development and manufacturing of advanced optical and photonics solutions. They design and produce innovative products and systems for various industries including aerospace, defense, telecommunications, and medical.

The company is known for its expertise in optical fibers, lasers, and photonics components, which are used in a wide range of applications such as communication networks, high-speed data transmission, sensing technologies, and medical imaging devices.

Procyon Corporation has a team of highly skilled engineers and scientists who work on cutting-edge research and development projects. They also have state-of-the-art manufacturing facilities that enable them to produce high-quality products with strict quality control standards.

With their focus on innovation and technological advancements, Procyon Corporation aims to provide solutions that meet the evolving needs of their clients and contribute to the progress of various industries.


   Company Address: 164 Douglas Rd Oldsmar 34677 FL
   Company Phone Number: 447-2998   Stock Exchange / Ticker: PCYN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Procyon Corporation

Procyon Corporation's Deficit Surges in Q1 2024, Despite Positive Profitability Trend



In the volatile world of the stock market, finding companies that defy industry trends and consistently outperform their peers is a goldmine for investors. Procyon Corporation, a leading player in the Major Pharmaceutical Preparations industry, has recently released its financial report for the period January to March 31, 2024. The results show a remarkable improvement in key indicators, highlighting the company's resilience and ability to navigate challenging market conditions.
Impressive Financial Results
During the specified reporting period, Procyon Corporation witnessed a significant expansion in its deficit, increasing from $0.00 to $-0.01 per share compared to the previous year. However, the company managed to improve its earnings per share (EPS) from $-0.03 to $-0.01 per share over the same timeframe, indicating a positive trajectory for the company's profitability.
Procyon Corporation

Procyon Corporation Surpasses Expectations with 1.361% Revenue Increase in Second Quarter of 2024

Procyon Corporation, a key player in the Major Pharmaceutical Preparations sector, has defied the odds by reporting an increase in revenue during the October to December 31, 2023 fiscal period. While many of its sector peers experienced business reductions, Procyon Corporation managed to grow its revenue by 1.361% to $1.20 million from $1.18 million in the same period last year.
Despite the positive revenue growth, Procyon Corporation did see an increase in its shortfall per share, from $0.00 a year ago to $0.03 per share in the current fiscal period. Additionally, the company reported a net shortfall of $-0.242 million, which was larger than the $-0.020 million shortfall from the previous year.
Procyon Corporation

Procyon Corporation Steams Ahead, Consolidating Revenue at PCYN in Record-breaking Quarter

Based on the financial time-frame ending September 30, 2023, Procyon Corporation has experienced significant declines and challenges, leading to a bearish outlook for the company. Depleting orders have played a crucial role in the losses incurred during this period.
The revenue for Procyon Corporation fell by -0.221% to $1.17 million compared to the previous reporting season, where revenue decreased by -2.42% from $1.20 million. This downward trend indicates a constant struggle for the company to maintain a steady revenue stream. It is clear that Procyon Corporation has been facing difficulties in generating consistent income.
Procyon Corporation

Observing the fourth quarter of 2023 numbers, Procyon Corporation reveals concerning revenue decline



Procyon Corporation recently released their financial results for the fourth quarter of the 2023 earnings season. While the company reported unaltered earnings per share (EPS), a decline in revenue and other key indicators raises concerns about the company's future performance. This article aims to interpret the financial results and discuss their potential impact on Procyon Corporation going forward.
1. Earnings per Share (EPS) and Revenue Performance:
Procyon Corporation maintained an EPS of $0.00 in the fourth quarter, suggesting stability in their profitability. However, the company experienced a modest revenue decline of -0.589% year-on-year, amounting to $1.20 million. This decline sets Procyon apart from the rest of the Major Pharmaceutical Preparations industry, which recorded a revenue improvement during the same period.
Procyon Corporation

Procyon Corporation Records Steady Revenue Growth of 1.108% to $1.12M in Q3 2023, Achieving Break-Even Status

Procyon Corporation, a major pharmaceutical preparations company, recently announced its financial report for the third quarter of 2023, showing a break-even on moderate revenue advance of 1.108% to $1.12 million from the same quarter in the previous year. In comparison to the prior quarter, the revenue decreased by -4.993% from $1.18 million and earnings per share were $0.00.
In addition, Procyon Corporation reported a net shortfall of $-0.029 million during the third quarter of 2023, which is a significant improvement from the previous year's corresponding quarter, where the shortfall was $-0.105 million. The company is expected to report its next financial numbers on September 27, 2023.






Procyon's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com